The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

30 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
The Essential Medicinal Chemistry of Curcumin.EBI
University Of Minnesota
Design and synthesis of curcumin derivatives as tau and amyloidß dual aggregation inhibitors.EBI
Doshisha University
Design, Synthesis, and Characterization of 3-(Benzylidene)indolin-2-one Derivatives as Ligands fora-Synuclein Fibrils.EBI
Washington University
Development of dual targeting inhibitors against aggregations of amyloid-ß and tau protein.EBI
Tokyo Institute Of Technology
Imidazo[2,1]thiazol-3-one Derivatives Useful as Diagnostic Agents for Alzheimer's Disease.EBI
Temple University School Of Pharmacy
Synthesis and biological evaluation of novel styryl benzimidazole derivatives as probes for imaging of neurofibrillary tangles in Alzheimer's disease.EBI
Kyoto University
Progress and developments in tau aggregation inhibitors for Alzheimer disease.EBI
Humboldt Universit£T Zu Berlin
Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.EBI
Northwestern University
2-Styrylindolium based fluorescent probes visualize neurofibrillary tangles in Alzheimer's disease.EBI
Technische Universit£T Darmstadt
Evaluation of [(11)C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles.EBI
TBA
Bis(arylvinyl)pyrazines, -pyrimidines, and -pyridazines as imaging agents for tau fibrils andß-amyloid plaques in Alzheimer's disease models.EBI
Technische Universit£T Darmstadt
Novel compounds for the treatment of neurodegenerative diseases: patent highlight.EBI
TBA
Synthesis and biological evaluation of novel oxindole derivatives for imaging neurofibrillary tangles in Alzheimer's disease.EBI
Kyoto University
(18)F-labeled phenyldiazenyl benzothiazole for in vivo imaging of neurofibrillary tangles in Alzheimer's disease brains.EBI
TBA
PROTACs to address the challenges facing small molecule inhibitors.EBI
Oregon Health & Science University
Amyloid-? and tau aggregation dual-inhibitors: A synthetic and structure-activity relationship focused review.EBI
University Of Aveiro
Small molecule therapeutics for tauopathy in Alzheimer's disease: Walking on the path of most resistance.EBI
Karolinska Institutet
Structure-activity relationship around PI-2620 highlights the importance of the nitrogen atom position in the tricyclic core.EBI
Ac Immune
The multifunctional dopamine DEBI
Oakland University
Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease.EBI
Jining Medical University
Regioselective synthesis of 7-O-esters of the flavonolignan silibinin and SARs lead to compounds with overadditive neuroprotective effects.EBI
Julius-Maximilians-Universit£T W£Rzburg
Discovery of a Keap1-dependent peptide PROTAC to knockdown Tau by ubiquitination-proteasome degradation pathway.EBI
China Pharmaceutical University